STRONGBRIDGE BIOPHARMA plc Operating Income
STRONGBRIDGE BIOPHARMA plc reported Operating Income of -$13.06 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2021-08-05
- STRONGBRIDGE BIOPHARMA plc operating income (loss) for the quarter ending 2021-06-30 was -$13.06M.
- STRONGBRIDGE BIOPHARMA plc operating income (loss) for the quarter ending 2021-03-31 was -$10.07M.
- STRONGBRIDGE BIOPHARMA plc operating income (loss) for the quarter ending 2020-12-31 was -$10.40M.
- STRONGBRIDGE BIOPHARMA plc operating income (loss) for the quarter ending 2020-09-30 was -$9.58M.
- STRONGBRIDGE BIOPHARMA plc operating income (loss) for fiscal 2020 was -$43.16M.
- STRONGBRIDGE BIOPHARMA plc operating income (loss) for fiscal 2019 was -$67.09M.
- STRONGBRIDGE BIOPHARMA plc operating income (loss) for fiscal 2018 was -$81.92M.
- STRONGBRIDGE BIOPHARMA plc operating income (loss) for fiscal 2017 was -$73.74M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$13.06M 10-Q · filed 2021-08-05 | -$23.13M 10-Q · filed 2021-08-05 | -$33.53M derived: sum of 3 quarters · filed 2021-08-05 | -$43.12M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | -$10.07M 10-Q · filed 2021-05-12 | -$20.47M derived: sum of 2 quarters · filed 2021-05-12 | -$30.05M derived: sum of 3 quarters · filed 2021-05-12 | -$39.73M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | -$10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$19.98M derived: sum of 2 quarters · filed 2021-03-03 | -$29.66M derived: sum of 3 quarters · filed 2021-08-05 | -$43.16M 10-K · filed 2021-03-03 |
| 2020-09-30 | -$9.58M 10-Q · filed 2020-10-29 | -$19.26M derived: sum of 2 quarters · filed 2021-08-05 | -$32.77M 10-Q · filed 2020-10-29 | -$49.40M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | -$9.68M 10-Q · filed 2021-08-05 | -$23.18M 10-Q · filed 2021-08-05 | -$39.82M derived: sum of 3 quarters · filed 2021-08-05 | -$56.75M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$13.51M 10-Q · filed 2021-05-12 | -$30.14M derived: sum of 2 quarters · filed 2021-05-12 | -$47.07M derived: sum of 3 quarters · filed 2021-05-12 | -$64.19M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$16.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$33.56M derived: sum of 2 quarters · filed 2021-03-03 | -$50.68M derived: sum of 3 quarters · filed 2021-03-03 | -$67.09M 10-K · filed 2021-03-03 |
| 2019-09-30 | -$16.93M 10-Q · filed 2020-10-29 | -$34.05M derived: sum of 2 quarters · filed 2020-10-29 | -$50.46M 10-Q · filed 2020-10-29 | -$72.85M derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-06-30 | -$17.12M 10-Q · filed 2020-08-04 | -$33.53M 10-Q · filed 2020-08-04 | -$55.92M derived: sum of 3 quarters · filed 2021-03-03 | -$80.65M derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-03-31 | -$16.41M 10-Q · filed 2020-05-06 | -$38.80M derived: sum of 2 quarters · filed 2021-03-03 | -$63.53M derived: sum of 3 quarters · filed 2021-03-03 | -$82.52M derived: sum of 4 quarters · filed 2021-03-03 |
| 2018-12-31 | -$22.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$47.12M derived: sum of 2 quarters · filed 2021-03-03 | -$66.11M derived: sum of 3 quarters · filed 2021-03-03 | -$81.92M 10-K · filed 2021-03-03 |
| 2018-09-30 | -$24.73M 10-Q · filed 2019-11-07 | -$43.72M derived: sum of 2 quarters · filed 2019-11-07 | -$59.53M 10-Q · filed 2019-11-07 | -$73.70M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$18.99M 10-Q · filed 2019-07-31 | -$34.80M 10-Q · filed 2019-07-31 | -$48.97M derived: sum of 3 quarters · filed 2020-02-28 | -$81.99M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$15.81M 10-Q · filed 2019-05-01 | -$29.97M derived: sum of 2 quarters · filed 2020-02-28 | -$63.00M derived: sum of 3 quarters · filed 2020-02-28 | -$77.37M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$14.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$47.19M derived: sum of 2 quarters · filed 2020-02-28 | -$61.56M derived: sum of 3 quarters · filed 2020-02-28 | -$73.74M 10-K · filed 2020-02-28 |
| 2017-09-30 | -$33.02M 10-Q · filed 2018-10-31 | -$47.40M derived: sum of 2 quarters · filed 2018-10-31 | -$59.58M 10-Q · filed 2018-10-31 | -$77.93M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$14.37M 10-Q · filed 2018-08-08 | -$26.55M 10-Q · filed 2018-08-08 | -$44.91M derived: sum of 3 quarters · filed 2019-02-27 | -$52.54M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$12.18M 10-Q · filed 2018-05-10 | -$30.54M derived: sum of 2 quarters · filed 2019-02-27 | -$38.17M derived: sum of 3 quarters · filed 2019-02-27 | -$51.98M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$18.36M derived: 10-K 12 month − 6-K 9 month · filed 2019-02-27 | -$25.99M derived: sum of 2 quarters · filed 2019-02-27 | -$39.80M derived: sum of 3 quarters · filed 2019-02-27 | -$50.73M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$7.63M 6-K · filed 2017-11-14 | -$21.45M derived: sum of 2 quarters · filed 2017-11-14 | -$32.37M 6-K · filed 2017-11-14 | -$42.74M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$13.81M 6-K · filed 2017-08-07 | -$24.74M 6-K · filed 2017-08-07 | -$35.11M derived: sum of 3 quarters · filed 2018-03-12 | -$44.75M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | -$10.92M 6-K · filed 2017-05-16 | -$21.29M derived: sum of 2 quarters · filed 2018-03-12 | -$30.94M derived: sum of 3 quarters · filed 2018-03-12 | -$48.17M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$10.37M derived: 10-K 12 month − 6-K 9 month · filed 2018-03-12 | -$20.02M derived: sum of 2 quarters · filed 2018-03-12 | -$37.25M derived: sum of 3 quarters · filed 2018-03-12 | -$42.85M 10-K · filed 2018-03-12 |
| 2015-09-30 | -$9.64M 6-K · filed 2016-12-30 | -$26.88M derived: sum of 2 quarters · filed 2016-12-30 | -$32.48M 6-K · filed 2016-12-30 | |
| 2015-06-30 | -$17.23M 6-K · filed 2016-12-30 | -$22.84M 6-K · filed 2016-12-30 | ||
| 2015-03-31 | -$5.61M 6-K · filed 2016-05-17 | |||
| 2014-12-31 | -$10.43M 20-F · filed 2017-04-04 | |||
| 2013-12-31 | -$5.19M 20-F · filed 2016-03-24 |